The Latest Life Sciences Tools & Diagnostics Articles from Streetwise Reports


Is Reliq Health Technologies a Nutrimental 'Buy'?

Contributed Opinion
  ()
After recovering from a short "character assassination," Reliq Health Technologies may be on the up-and-up. Clive Maund examines the latest data from the company to see if it would make a good 'buy'.

Co. to Rebound After Q4/21 Sales Down Due to Virus Surge

Research Report
  ()
The 2022 outlook for a cancer detection and therapy solutions company is positive given its focus on dermatology and implementing new commercial strategies, noted an Oppenheimer report.

Biotech Could Launch Trial of Polyp Screening Test in March

Research Report
  ()
The start of the C-Scan study would be a major milestone for Check-Cap, noted an H.C. Wainwright & Co. report.

Co.'s COVID-19 Test Detects Omicron Variant

Research Report
  ()
H.C. Wainwright & Co. gives Sorrento Therapeutics a Buy rating after initial testing shows its COVISTIX detects COVID-19's Omicron variant.

Showing Results: 1 to 8 of 8

Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe